Are current wound classifications valid for predicting prognosis in people treated for limb-threatening diabetic foot ulcers? Int Wound J. 2023; 1-9. DOI: 10.1111/iwj14338. Chang YC, Huang YY, Hung SY, Yeh JT, Lin CW, Chen IW, Wei HH, Yang HM, Huang CH*.
Diabetic foot disease in subjects with End-stage renal Disease: A nationwide study over 14 years highlighting an emerging threat. Diabetes Res Clin Pract 2022; 193:110134. Lin CH, Armstrong DG, Huang CH, Lin CH, Hung SY, Liu PH, Huang YY.
Survival of patients following first diagnosis of diabetic foot complications: A nationwide 15-year longitudinal analysis. Frontiers in Endocrinology. 2021 DOI:10.3389/fendo.2021.801324. Lin CH, Armstrong DG, Liu PH, Lin CW, Huang CH, Huang YY*.
A comprehensive investigation of nutritional status and psoas muscle mass in predicting five-year survival in patients with liver transplant. J Formos Med Assoc 2021; S0929-6646(21)00461-7. Tsao YZ, Lee WC, Huang CH, Lin IH, Huang YY*.
Impact of wound microbiology on limb preservation in patients with diabetic foot infection. J Diabetes Invest 2021; doi: 10.1111/jdi.13649. Hung SY, Chiu CH, Huang CH, Lin CW, Yeh JT, Yang HM, Huang YY*.
Modifiable factors related to 7-year renal outcomes in subjects with type 2 diabetes and chronic kidney disease stage 3. Journal of Postgraduate Medicine 2020; 66(4): 187-193. Huang CH, Chen CP, Huang YY, Hsu BRS*.
Amino acids and wound healing in people with limb-threatening diabetic foot ulcers. J of Diabetes and its Complications 2019; 33: 107403. Hung SY, Tsai JS, Yeh JT, Chen KH, Lin CN, Yang HM, Lin CW, Chen HY, Huang CH, Huang YY*.
Diabetic Foot Infection presenting systemic inflammatory response syndrome: A unique disorder of systemic reaction from infection of the most distal body. Journal of Clinical Medicine 2019; 8(10): 1538. Lin CW, Hung SY, Huang CH, Yeh JT, Huang YY*.
Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period. BMJ Open Diabetes Research & Care 2019; 7: e000795. Lin CW, Armstrong DG, Lin CH, Liu PH, Hung SY, Lee SR, Huang CH, Huang YY*.
The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: a randomized, double-blind, placebo-controlled pilot trial. PloS one, 2019, 14.8: e0221199. Huang YH, Chen ST, Liu FH, Hsieh SH, Lin CH, Liou MJ, Wang CC, Huang CH, Liu GH, Lin JR, Yang LY, Hsu TY, Lee MC, Huang CT, Wu YH*.
Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes. J of Global Antimicrobial Resistance 2018; 15: 271-276. Huang CH, Chiu CH, Chen IW, Hung SY, Lin CW, Hsu BRS, Huang YY*.
A short-term follow-up of glycemic and body weight changes in diabetic patients who replaced dipeptidyl peptidase-4 inhibitors with the sodium-glucose cotransporter 2 inhibitor empagliflozin. Ann Saudi Med 2018; 38: 420-426. Huang CH, Huang YY, Hsu BRS*.